Evidence map›Paper›PMID 23465084›Full record

ArticleActa psychiatrica Scandinavica2014

General medical burden in bipolar disorder: findings from the LiTMUS comparative effectiveness trial.

D E Kemp, L G Sylvia, J R Calabrese, A A Nierenberg, M E Thase, N A Reilly-Harrington, M J Ostacher, A C Leon, T A Ketter, E S Friedman and 5 more

Abstract read
In one paragraph

Article in Acta psychiatrica Scandinavica, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Guideline
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Impaired Glucose Metabolism in Bipolar Patients: The Role of Psychiatrists in Its Detection and Management.International journal of environmental research and public health · 2019
    Article
  14. Review
  15. Dietary influences on cognition.Physiology & behavior · 2018
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors.

D E KempUniversity Hospitals Case Medical Center, Case Western Reserve University, Cleveland, OH, USA.
L G Sylvia
J R Calabrese
A A Nierenberg
M E Thase
N A Reilly-Harrington
M J Ostacher
A C Leon
T A Ketter
E S Friedman
C L Bowden
D J Rabideau
M Pencina
D V Iosifescu
LiTMUS Study Group

Funding

University of Pittsburgh Clinical and Translational Science InstituteUL1TR000005 · NCATS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI REIS, STEVEN E · 2012 to 2015
$50.8M
Clinical and Translational Science Collaborative of ClevelandKL2TR000440 · NCATS · CASE WESTERN RESERVE UNIVERSITY · PI KONSTAN, MICHAEL W. · 2012 to 2016
$11.1M
TREATMENT OF BIPOLAR DISORDER-278980001N01MH080001 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · 1998 to 2003
$5.3M
NCATS NIH HHS KL2 TR000440NCATS NIH HHS UL1 TR000005NIMH NIH HHS N01 MH080001
6 · The paper itself

Abstract

objectiveThis study examined general medical illnesses and their association with clinical features of bipolar disorder.

methodData were cross-sectional and derived from the Lithium Treatment - Moderate Dose Use Study (LiTMUS), which randomized symptomatic adults (n = 264 with available medical comorbidity scores) with bipolar disorder to moderate doses of lithium plus optimized treatment (OPT) or to OPT alone. Clinically significant high and low medical comorbidity burden were defined as a Cumulative Illness Rating Scale (CIRS) score ≥4 and <4 respectively.

resultsThe baseline prevalence of significant medical comorbidity was 53% (n = 139). Patients with high medical burden were more likely to present in a major depressive episode (P = .04), meet criteria for obsessive-compulsive disorder (P = .02), and experience a greater number of lifetime mood episodes (P = 0.02). They were also more likely to be prescribed a greater number of psychotropic medications (P = .002). Sixty-nine per cent of the sample was overweight or obese as defined by body mass index (BMI), with African Americans representing the racial group with the highest proportion of stage II obesity (BMI ≥35; 31%, n = 14).

conclusionThe burden of comorbid medical illnesses was high in this generalizable sample of treatment-seeking patients and appears associated with worsened course of illness and psychotropic medication patterns.

Indexed as

AdolescentAdultAgedAsianAsthmaBipolar DisorderBlack or African AmericanBody Mass IndexComorbidityFemaleHumansHyperlipidemiasHypertensionMaleMetabolic SyndromeMiddle AgedPsychotropic Drugsbipolar disordereffectivenesslithiummedical comorbidityobesity

Identifiers

PMID23465084
PMCPMC3789858

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.